DANIEL SILVER: Open Payments
NPI 1376535831 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,147 in 153 payments from 26 companies in 2025. Trend: 2023 $3,373 · 2024 $3,336 · 2025 $4,147
Food & beverage: $4,011Education: $85Speaker / faculty: $51
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 36 | $1,520 |
| Antares Pharma, Inc. | 24 | $397 |
| Janssen Biotech, Inc. | 10 | $287 |
| PROGENICS PHARMACEUTICALS, INC. | 10 | $254 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $193 |
| Endo USA, Inc. | 14 | $183 |
| UROGEN PHARMA, INC. | 7 | $158 |
| Blue Earth Diagnostics | 5 | $150 |
| Merck Sharp & Dohme LLC | 5 | $132 |
| IMMUNITYBIO, INC. | 2 | $115 |
Products named: PROVENGE, XYOSTED, PYLARIFY, AVEED, ERLEADA, POSLUMA, Xofigo, RYBREVANT.
Industry payments across AZ — which companies pay providers there.
